Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Pricing Hearing In Senate Postponed, Handing Innovators Another Victory

Executive Summary

First hearing in Sen. Alexander's committee was dominated by Democrat complaints about Obamacare repeal; now that there's an actual bill to criticize, the next one might have been even worse, but regardless of the reason, the postponement means innovator prices get to stay out of the spotlight once again.

Advertisement

Related Content

Drug Pricing, Supply Chain Issues May Get House Hearing
FDARA Takes Effect With Under-The-Radar Presidential Signature
FDARA Takes Effect With Under-The-Radar Presidential Signature
Sen. Cassidy Suggests Importing Generics From EU To Pressure US Prices
Sen. Cassidy Suggests Importing Generics From EU To Pressure US Prices
User Fee Bill Or Drug Pricing Bill? House Members Makes Both Cases
Drug Pricing 'Deeper Dive' Planned By Senate Cmte. As Industry Avoids First Blood
Biopharma Largely Avoids Partisan Bloodbath At US Pricing Hearing
FDA User Fee Bill: House Cmte. Makes Technical Changes, Adds Pricing Resolution
Drug Importation Blocked But Not Forgotten As User Fee Bill Clears Senate Cmte

Topics

Advertisement
UsernamePublicRestriction

Register

PS121002

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel